Profiel
Samuil Umansky is the founder of Cardiff Oncology, Inc., which was founded in 1999.
He held the title of President from 1999 to 2006.
Currently, he is the President & Chief Scientific Officer at DiamiR LLC.
Actieve functies van Samuil Umansky
| Bedrijven | Functie | Begin |
|---|---|---|
DiamiR LLC
 DiamiR LLC BiotechnologyHealth Technology Part of DiamiR Biosciences Corp., DiamiR LLC engages in the development and commercialization of technology based on the analysis of brain-enriched microRNA biomarkers in blood plasma. The company is based in Monmouth Junction, NJ. The company was founded by Kira S. Sheinerman. Alidad Mireskandari has been the CEO of the company since 2022. | President | - |
Eerdere bekende functies van Samuil Umansky
| Bedrijven | Functie | Einde |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
DiamiR LLC
DiamiR LLC BiotechnologyHealth Technology Part of DiamiR Biosciences Corp., DiamiR LLC engages in the development and commercialization of technology based on the analysis of brain-enriched microRNA biomarkers in blood plasma. The company is based in Monmouth Junction, NJ. The company was founded by Kira S. Sheinerman. Alidad Mireskandari has been the CEO of the company since 2022. | Health Technology |